Unresectable Desmoid-Type Fibromatosis clinical trials at UC Health
1 research study open to eligible people
open to eligible people ages 12 months to 18 years
This phase II trial studies the side effects and how well nirogacestat works in treating patients with desmoid tumors that has grown after at least one form of treatment by mouth or in the vein that cannot be removed by surgery. Nirogacestat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
at UC Davis UCLA UCSF